Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1993-09-01
1995-08-01
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Lymphokine
424 852, A61K 3818, A61K 3819, A61K 3820
Patent
active
054378630
ABSTRACT:
A method of restoring damaged or depleted cell populations by treating the patient with cytokines, particularly IL-11 and IL-6.
REFERENCES:
patent: 5082658 (1992-01-01), Palladino
patent: 5214066 (1993-05-01), Szabo
patent: 5215895 (1993-06-01), Bennett et al.
patent: 5262319 (1993-11-01), Iwata et al.
Wu et al., Radiation Res. 123: 112-115 ('90).
Du et al., Blood 83(1): 33-37 ('94).
Wilmore et al., Surgery 104(5): 917-923 ('88).
Steadman's Medical Dictionary, 25th Ed., Williams and Wilkins, Baltimore, Md., 1990, pp. 34-35, 395-396.
F. Takatsuki et al, "Interleukin 6 Perfusion Stimulates Reconstitution of the Immune and Hematopoietic Systems after 5-Fluorouracil Treatment", Cancer Research, 50:2885-2890 (May 15, 1990).
D. P. Gearing et al, "the IL-6 Signal Transducer, gp130: An Oncostatin M Receptor and Affinity Converter for the LIF Receptor", Science, 255:1434-1437 (Mar. 13, 1992).
N. Y. Ip et al, "CNTF and LIF Act on Neuronal Cells via Shared Signaling Pathways that Involve the IL-6 Signal Transducing Receptor Component gp130", Cell, 69:1121-1132 (Jun. 26, 1992).
G. Damia et al, "Prevention of Acute Chemotherapy-induced Death in Mice by Recombinant Human Interleukin 1: Protection from Hematological and Nonhematological Toxicities", Cancer Research, 52:4082-4089 (Aug. 1, 1992).
K. M. Zsebo et al, "Radioprotection of Mice by Recombinant Rat Stem Cell Factor", Proc. Natl. Acad. Sci. USA, 89:9464-9468 (Oct. 1992).
R. Neta et al, "The in vivo Effects of Interleukin 1: Bone Marrow Cells are Induced to Cycle after Administration of Interleukin 1", J. Immunol., 139(6):1861-1866 (Sep. 15, 1987) [Neta I].
R. Neta et al, "Interleukin 1 is a Radioprotector", J. Immunol., 136(7):2483-2485 (Apr. 1, 1986) [Neta II].
J. L. Gabrilove et al, "Effect of Granulocyte Colony-Stimulating Factor on Nuetropenia and Associated Morbidity due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium", The new England Journal of Medicine, 318(22):1414-1422 (Jun. 2, 1988).
S. Vadhan-Raj et al, "Abrogating Chemotherapy-Induced Myelosuppression by Recombinant Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Sarcoma: Protection at the Progenitor Cell Level", J. Clin. Oncology, 10(8):1266-1277 (Aug. 1992).
X. Du et al, "Effects of Recombinant Human Interleukin-11 on Hematopoietic Reconstitution in Transplant Mice: Acceleration of Recovery of Peripheral Blood Neutrophils and Platelets", Blood, 81(1):27-34 (Jan. 1, 1993).
S. Paul et al, "Molecular Cloning of a cDNA Encoding Interleukin 11, a Stromal Cell-Derived Lymphopoietic and Hematopoietic Cytokine", Proc. Natl. Acad. Sci. USA, 87:7512-7516 (Oct. 1990).
F. Balkwill et al, "The Cytokine Network", Immunology Today, 10(9):299-304 (1989).
S. Clark et al, "The Human Hematopoietic Colony-Stimulating Factors", Science, 236:1229-1237 (Jun. 5, 1987).
Clark Steven C.
Williams David A.
Bak Mary E.
DesRosier Thomas J.
Genetics Institute Inc.
Grimes Eric
Meinert M. C.
LandOfFree
Method of enhancing the growth of gut epithelial cells by admini does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of enhancing the growth of gut epithelial cells by admini, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of enhancing the growth of gut epithelial cells by admini will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-732747